Susceptibility profiles and resistance genomics of Pseudomonas aeruginosa isolates from European ICUs participating in the ASPIRE-ICU trial.

Gabriel TorrensThomas Ewout van der SchalkSara Cortes-LaraLeen TimbermontEster Del Barrio-TofiñoBasil Britto XavierLaura ZamoranoChristine LammensOmar AliAlexey RuzinHerman GoossensSamir Kumar-SinghJan KluytmansFleur PalingR Craig MacLeanThilo KöhlerCarla López-CausapéSurbhi Malhotra-KumarAntonio Olivernull null

Published in: The Journal of antimicrobial chemotherapy (2022)

An overall high prevalence of resistance is documented European ICUs, but with a wide intercountry variability determined by the dissemination of XDR high-risk clones, arguing for the need to reinforce infection control measures.

Keyphrases

pseudomonas aeruginosa
intensive care unit
cystic fibrosis
drug resistant

clinical trial
study protocol
single cell

phase iii
phase ii
biofilm formation

acinetobacter baumannii
mechanical ventilation
open label